Cell counting and characterization
Empowering cell-based research with automated counting and cytometry solutions
As part of our comprehensive pre-clinical development offerings, Revvity includes Nexcelom's automated cell counting and image cytometry solutions. These systems provide fast and reliable assessments of cell health, viability, and immunophenotyping, essential for pre-clinical research. Our portfolio features advanced instruments like the Cellometer™, Cellaca™ MX, Cellaca PLX, and Celigo™, supported by a wide range of reagents and consumables to streamline routine cell-based assays with precision.
Cell Counting and Image Cytometry
Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables.
Cellular imaging and analysis
Make discoveries faster with cellular imaging
With over two decades of experience, we offer a comprehensive portfolio of cellular imaging products designed to accelerate your research. From high-content imaging instruments and image analysis software to fluorescent probes, microplates, and automation solutions, our tools help you answer complex biological questions with precision. Our High-Content Screening (HCS) combines automated imaging and analysis to extract detailed quantitative data at the single-cell level, enabling deeper insights into disease models, toxicity effects, and predictive biomarkers.
Cellular Imaging & Analysis
With more than a decade of experience in this field, Revvity provides a portfolio of cellular Imaging products
In vivo imaging
Advance your pre-clinical development with in vivo Imaging
Accurate evaluation of gene and cell therapy candidates relies on understanding biological processes and tracking disease progression. Our in vivo imaging solutions offer non-invasive, real-time insights into molecular and physiological changes, crucial for optimizing and validating therapeutic strategies in pre-clinical research. Our best-in-class imaging systems enable researchers to identify early disease indicators, monitor therapeutic responses, and gain deeper insights into key biological pathways. With over 20,000 peer-reviewed publications, our imaging technologies are trusted to meet the rigorous demands of pre-clinical development.
In Vivo Imaging
Tracking, monitoring, and visualizing biological processes and disease progression is key to not only helping you better understand biology but also crucial in evaluating the effectiveness of your potential drug candidates earlier in the development process.
Organoid development
Advance pre-clinical research with organoid development
Organoid development represents a significant advancement in pre-clinical research, using 3D cell culture models that closely replicate the genetic and morphological complexity of human tissues, organs, or tumors. These models provide a reliable platform for expanding drug testing, evaluating therapeutic responses, and gaining deeper insights into disease mechanisms. However, the inherent variability of organoids, specific media requirements, and the absence of fully automated workflows highlight the ongoing need for innovation to maintain consistency and clinical relevance in pre-clinical development.
GrowDex Hydrogels
We offer a range of products for scalable animal-free 3D cell culture applications, providing convenience and consistent results.
Cell-Vive GMP Reagents
BioLegend’s Cell-Vive™ GMP portfolio offers animal-free, ex vivo cell culture products and ancillary reagents, designed and manufactured under strict guidelines for batch-to-batch consistency and traceability. With independent QA oversight and adherence to key regulatory standards, these products provide reliable solutions for cell processing and downstream manufacturing.
Bioanalytical assay development
Accelerate and enhance bioanalytical assay development
Our bioanalytical assay development toolkit features AlphaLISA™ technology for rapid, no-wash detection of capsid proteins, enabling precise quantification in complex samples. For in-depth characterization of AAV capsid proteins and nucleic acids, the LabChip® GXII Touch™ system provides an automated, high-throughput solution, offering results in as little as 42 seconds per sample. This advanced system not only speeds up analysis but also enhances data quality, supporting a wide range of assays critical to biotherapeutics and genomics research.
